1-methyl-3-isobutylxanthine has been researched along with mre 269 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Islam, MS; Jisaka, M; Khan, F; Nartey, MN; Nishimura, K; Rahman, MS; Shono, F; Syeda, PK; Yokota, K | 1 |
1 other study(ies) available for 1-methyl-3-isobutylxanthine and mre 269
| Article | Year |
|---|---|
Pretreatment of cultured preadipocytes with arachidonic acid during the differentiation phase without a cAMP-elevating agent enhances fat storage after the maturation phase.
Topics: 1-Methyl-3-isobutylxanthine; 3T3-L1 Cells; 6-Ketoprostaglandin F1 alpha; Acetates; Adipocytes; Adipogenesis; Animals; Arachidonic Acid; Cell Differentiation; Cells, Cultured; Cyclic AMP; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; Gene Expression Regulation; Humans; Hydroxyprostaglandin Dehydrogenases; Membrane Proteins; Mesenchymal Stem Cells; Mice; Prostaglandin-E Synthases; Pyrazines; Receptors, Prostaglandin; Receptors, Prostaglandin E, EP4 Subtype; Signal Transduction; Triglycerides | 2016 |